Archives of Virology

, Volume 158, Issue 11, pp 2365–2370 | Cite as

Oseltamivir-resistant influenza viruses isolated in South Korea from 2005 to 2010

  • Han-Gil Cho
  • Jang-Hoon Choi
  • Hyun-Kyung Lee
  • Su-Kyoung Mun
  • Jong-Bok Lee
  • Eek-Hoon Jho
  • Chun Kang
  • Young-Hee Lim
Brief Report

Abstract

South Korean isolates of oseltamivir-resistant influenza viruses from 2005–2010 were investigated with a total 491 influenza viruses identified from 1702 specimens. Neuraminidase genes from 342 influenza viruses (71 A/H1N1, 74 pandemic A/H1N1 2009, 117 A/H3N2, and 80 B) were analyzed by RT-PCR with molecular markers for oseltamivir resistance. The H274Y mutation in the NA protein was identified in 100 % (n=40) of A/H1N1 viruses circulating in 2008–2009. Influenza A/H1N1 viruses harboring the H274Y substitution exhibited, on average, a 626-fold reduction in oseltamivir susceptibility and clustered with the A/Norway/1736/2007 strain. Close and timely monitoring for resistance to clinically available influenza antivirals should be consistently performed.

Keywords

Influenza viruses Neuraminidase Oseltamivir resistance 

Supplementary material

705_2013_1734_MOESM1_ESM.doc (174 kb)
Supplementary material 1 (DOC 173 kb)

References

  1. 1.
    Cox NJ, Subbarao K (2000) Global epidemiology of influenza: past and present. Annu Rev Med 51:407–421PubMedCrossRefGoogle Scholar
  2. 2.
    Xu X, Subbarao K, Cox NJ, Guo Y (1999) Genetic characterization of the pathogenic influenza A/Goose/Guangdong/1/96 (H5N1) virus: similarity of its hemagglutinin gene to those of H5N1 viruses from the 1997 outbreaks in Hong Kong. Virology 261:15–19PubMedCrossRefGoogle Scholar
  3. 3.
    Garten RJ, Davis CT, Russell CA et al (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325:197–201PubMedCrossRefGoogle Scholar
  4. 4.
    Lackenby A, Thompson CI, Democratis J (2008) The potential impact of neuraminidase inhibitor resistant influenza. Curr Opin Infect Dis 21:626–638PubMedCrossRefGoogle Scholar
  5. 5.
    Bright RA, Medina MJ, Xu X, Perez-Oronoz G, Wallis TR, Davis XM, Povinelli L, Cox NJ, Klimov AI (2005) Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern. Lancet 366:1175–1181PubMedCrossRefGoogle Scholar
  6. 6.
    Moscona A (2005) Neuraminidase inhibitors for influenza. N Engl J Med 353:1363–1373PubMedCrossRefGoogle Scholar
  7. 7.
    Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV (2008) Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008. Antimicrob Agents Chemother 52:3284–3292PubMedCrossRefGoogle Scholar
  8. 8.
    Hauge SH, Dudman S, Borgen K, Lackenby A, Hungnes O (2009) Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007–08. Emerg Infect Dis 15:155–162PubMedCrossRefGoogle Scholar
  9. 9.
    Hurt AC, Ernest J, Deng YM, Iannello P, Besselaar TG, Birch C, Buchy P, Chittaganpitch M, Chiu SC, Dwyer D, Guigon A, Harrower B, Kei IP, Kok T, Lin C, McPhie K, Mohd A, Olveda R, Panayotou T, Rawlinson W, Scott L, Smith D, D’Souza H, Komadina N, Shaw R, Kelso A, Barr IG (2009) Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa. Antiviral Res 83:90–93PubMedCrossRefGoogle Scholar
  10. 10.
    Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H (2010) Emergence of H274Y oseltamivir-resistant A (H1N1) influenza viruses in Japan during the 2008–2009 season. J Clin Virol 47:23–28PubMedCrossRefGoogle Scholar
  11. 11.
    Eshaghi A, Bolotin S, Burton L, Low DE, Mazzulli T, Drews SJ (2009) Genetic microheterogeneity of emerging H275Y influenza virus A(H1N1) in Toronto, Ontario, Canada from the 2007–2008 respiratory season. J Clin Virol 45:142–145PubMedCrossRefGoogle Scholar
  12. 12.
    Dharan NJ, Gubareva LV, Meyer JJ, Okomo-Adhiambo M, McClinton RC, Marshall SA, St George K, Epperson S, Brammer L, Klimov AI, Bresee JS, Fry AM (2009) Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States. JAMA 301:1034–1041PubMedCrossRefGoogle Scholar
  13. 13.
    Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M (2009) Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007–08 season. Emerg Infect Dis 15:552–560PubMedGoogle Scholar
  14. 14.
    de Jong MD, Tran TT, Truong HK, Vo MH, Smith GJ, Nguyen VC, Bach VC, Phan TQ, Do QH, Guan Y, Peiris JS, Tran TH, Farrar J (2005) Oseltamivir resistance during treatment of influenza A (H5N1) infection. N Engl J Med 353:2667–2672PubMedCrossRefGoogle Scholar
  15. 15.
    Yi H, Lee JY, Hong EH, Kim MS, Kwon D, Choi JH, Choi WY, Kim KS, Lee JK, Oh HB, Kang C (2010) Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea. Emerg Infect Dis 16:1938–1942PubMedCrossRefGoogle Scholar
  16. 16.
    Yang JR, Huang YP, Lin YC, Su CH, Kuo CY, Hsu LC, Wu HS, Liu MT (2010) Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan. Antiviral Res 88:256–262PubMedCrossRefGoogle Scholar
  17. 17.
    Meijer A, Jonges M, van Beek P, Swaan CM, Osterhaus AD, Daniels RS, Hurt AC, Koopmans MP (2012) Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012. Euro Surveill 17:20266PubMedGoogle Scholar
  18. 18.
    Storms AD, Gubareva LV, Su S, Wheeling JT, Okomo-Adhiambo M, Pan CY, Reisdorf E, St George K, Myers R, Wotton JT, Robinson S, Leader B, Thompson M, Shannon M, Klimov A, Fry AM (2012) Oseltamivir-resistant pandemic (H1N1) 2009 virus infections, United States, 2010–11. Emerg Infect Dis 18:308–311PubMedCrossRefGoogle Scholar
  19. 19.
    Choi WY, Kim S, Lee N, Kwon M, Yang I, Kim MJ, Cheong SG, Kwon D, Lee JY, Oh HB, Kang C (2009) Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009. Antiviral Res 84:199–202PubMedCrossRefGoogle Scholar
  20. 20.
    Cho HG, Choi JH, Kim WH, Hong HK, Yoon MH, Jho EH, Kang C, Lim YH (2013) High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005–2010. Arch Virol 158:241–245PubMedCrossRefGoogle Scholar
  21. 21.
    Deyde VM, Sheu TG, Trujillo AA, Okomo-Adhiambo M, Garten R, Klimov AI, Gubareva LV (2010) Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob Agents Chemother 54:1102–1110PubMedCrossRefGoogle Scholar
  22. 22.
    Hatakeyama S, Sugaya N, Ito M, Yamazaki M, Ichikawa M, Kimura K, Kiso M, Shimizu H, Kawakami C, Koike K, Mitamura K, Kawaoka Y (2007) Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors. JAMA 297:1435–1442PubMedCrossRefGoogle Scholar
  23. 23.
    Monto AS, McKimm-Breschkin JL, Macken C, Hampson AW, Hay A, Klimov A, Tashiro M, Webster RG, Aymard M, Hayden FG, Zambon M (2006) Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use. Antimicrob Agents Chemother 50:2395–2402PubMedCrossRefGoogle Scholar
  24. 24.
    Ko JH, Kim JH, Kang JH, Eun BW, Kim KH, Hong JY, Oh SH (2012) Characteristics of hospitalized children with 2009 pandemic influenza A (H1N1): a multicenter study in Korea. J Korean Med Sci 27:408–415PubMedCrossRefGoogle Scholar
  25. 25.
    Shin SY, Kang C, Gwack J, Kim JH, Kim HS, Kang YA, Lee HG, Kim JS, Lee JK, Kim SH (2011) Drug-resistant pandemic (H1N1) 2009, South Korea. Emerg Infect Dis 17:702–704PubMedCrossRefGoogle Scholar
  26. 26.
    Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D, Barr IG (2012) Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia. J Infect Dis 206:148–157PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Han-Gil Cho
    • 2
    • 4
  • Jang-Hoon Choi
    • 3
  • Hyun-Kyung Lee
    • 2
  • Su-Kyoung Mun
    • 2
  • Jong-Bok Lee
    • 2
  • Eek-Hoon Jho
    • 4
  • Chun Kang
    • 3
  • Young-Hee Lim
    • 1
  1. 1.Department of Biomedical Science, College of Health ScienceKorea UniversitySeoulSouth Korea
  2. 2.Gyeonggi-do Institute of Health and EnvironmentSuwonSouth Korea
  3. 3.Center for Infectious DiseasesNational Institute of Health, Korea Centers for Disease Control and PreventionCheongwon-gunSouth Korea
  4. 4.University of SeoulSeoulSouth Korea

Personalised recommendations